Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kang Yi

Showing results (201-210 of 256) with videos related to

Pageof 26
Sort By:
Frontiers in Medicine|August 1, 2024
The Beijing angle closure progression study: design and methodologyZhi-Qiao Liang, Kang-Yi Yang, Kun Lv, et al.
DNA Repair|June 27, 2025
Proofreading of mismatches within primer-template junctions by Escherichia coli DNA polymerase I in vitro and in vivoHui-Lan Chang, Kang-Yi Su, Steven D Goodman, et al.
Neurobiology of Disease|December 26, 2025
APOE4 reduces hippocampal expression of phosphoglycerate kinase 1 and sodium potassium pump to enhance seizure susceptibility in miceTanveer Singh, Emma Bridgeman, Annie J Baker, et al.
Plos One|April 16, 2015
HOXA5 inhibits metastasis via regulating cytoskeletal remodelling and associates with prolonged survival in non-small-cell lung carcinomaChi-Chung Wang, Kang-Yi Su, Hsuan-Yu Chen, et al.
Plos One|May 19, 2012
Gene expression profiling of liver cancer stem cells by RNA-sequencingDavid W Y Ho, Zhen Fan Yang, Kang Yi, et al.
Lung Cancer (Amsterdam, Netherlands)|January 16, 2019
High PD-L1 expression correlates with primary resistance to EGFR-TKIs in treatment naïve advanced EGFR-mutant lung adenocarcinoma patientsKuo-Hsuan Hsu, Yen-Hsiang Huang, Jeng-Sen Tseng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2012
Pretreatment epidermal growth factor receptor (EGFR) T790M mutation predicts shorter EGFR tyrosine kinase inhibitor response duration in patients with non-small-cell lung cancerKang-Yi Su, Hsuan-Yu Chen, Ker-Chau Li, et al.
Cancer Research and Treatment|January 16, 2018
The Association of Acquired T790M Mutation with Clinical Characteristics after Resistance to First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung AdenocarcinomaYen-Hsiang Huang, Kuo-Hsuan Hsu, Jeng-Sen Tseng, et al.
Asian Journal of Andrology|December 20, 2022
Exosomes derived from BMSCs ameliorate cyclophosphamide-induced testosterone deficiency by enhancing the autophagy of Leydig cells via the AMPK-mTOR signaling pathwayHao-Yu Liang, Fan Peng, Min-Jia Pan, et al.
Cell Biology and Toxicology|May 1, 2026
DNAJB4/HLJ1 protects against acetaminophen-induced liver injury by attenuating ER stress via HSP70Chih-Yun Lu, Tsung-Hsuan Hsieh, Min-Hui Chien, et al.
Pageof 26

Showing results (201-210 of 256) with videos related to

Sort By:
Pageof 26
Frontiers in Medicine|August 1, 2024
The Beijing angle closure progression study: design and methodologyZhi-Qiao Liang, Kang-Yi Yang, Kun Lv, et al.
DNA Repair|June 27, 2025
Proofreading of mismatches within primer-template junctions by Escherichia coli DNA polymerase I in vitro and in vivoHui-Lan Chang, Kang-Yi Su, Steven D Goodman, et al.
Neurobiology of Disease|December 26, 2025
APOE4 reduces hippocampal expression of phosphoglycerate kinase 1 and sodium potassium pump to enhance seizure susceptibility in miceTanveer Singh, Emma Bridgeman, Annie J Baker, et al.
Plos One|April 16, 2015
HOXA5 inhibits metastasis via regulating cytoskeletal remodelling and associates with prolonged survival in non-small-cell lung carcinomaChi-Chung Wang, Kang-Yi Su, Hsuan-Yu Chen, et al.
Plos One|May 19, 2012
Gene expression profiling of liver cancer stem cells by RNA-sequencingDavid W Y Ho, Zhen Fan Yang, Kang Yi, et al.
Lung Cancer (Amsterdam, Netherlands)|January 16, 2019
High PD-L1 expression correlates with primary resistance to EGFR-TKIs in treatment naïve advanced EGFR-mutant lung adenocarcinoma patientsKuo-Hsuan Hsu, Yen-Hsiang Huang, Jeng-Sen Tseng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2012
Pretreatment epidermal growth factor receptor (EGFR) T790M mutation predicts shorter EGFR tyrosine kinase inhibitor response duration in patients with non-small-cell lung cancerKang-Yi Su, Hsuan-Yu Chen, Ker-Chau Li, et al.
Cancer Research and Treatment|January 16, 2018
The Association of Acquired T790M Mutation with Clinical Characteristics after Resistance to First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung AdenocarcinomaYen-Hsiang Huang, Kuo-Hsuan Hsu, Jeng-Sen Tseng, et al.
Asian Journal of Andrology|December 20, 2022
Exosomes derived from BMSCs ameliorate cyclophosphamide-induced testosterone deficiency by enhancing the autophagy of Leydig cells via the AMPK-mTOR signaling pathwayHao-Yu Liang, Fan Peng, Min-Jia Pan, et al.
Cell Biology and Toxicology|May 1, 2026
DNAJB4/HLJ1 protects against acetaminophen-induced liver injury by attenuating ER stress via HSP70Chih-Yun Lu, Tsung-Hsuan Hsieh, Min-Hui Chien, et al.
Pageof 26